234 related articles for article (PubMed ID: 34257820)
1. hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy.
Bai S; Xiong X; Tang B; Ji T; Li X; Qu X; Li W
Oxid Med Cell Longev; 2021; 2021():8814163. PubMed ID: 34257820
[TBL] [Abstract][Full Text] [Related]
2. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
[TBL] [Abstract][Full Text] [Related]
3. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway.
Zhang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484
[TBL] [Abstract][Full Text] [Related]
4. Diabetic nephropathy execrates epithelial-to-mesenchymal transition (EMT) via miR-2467-3p/Twist1 pathway.
Xu Y; Ouyang C; Lyu D; Lin Z; Zheng W; Xiao F; Xu Z; Ding L
Biomed Pharmacother; 2020 May; 125():109920. PubMed ID: 32050151
[TBL] [Abstract][Full Text] [Related]
5. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
Gao BH; Wu H; Wang X; Ji LL; Chen C
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
[TBL] [Abstract][Full Text] [Related]
6. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
7. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy.
Kang WL; Xu GS
Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039
[TBL] [Abstract][Full Text] [Related]
8. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
[TBL] [Abstract][Full Text] [Related]
9. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced activation of Twist/miR-214/E-cadherin axis promotes renal tubular epithelial cell mesenchymal transition and renal fibrosis.
Liu M; Liu L; Bai M; Zhang L; Ma F; Yang X; Sun S
Biochem Biophys Res Commun; 2018 Jan; 495(3):2324-2330. PubMed ID: 29277613
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy.
Wang X; Xu Y; Zhu YC; Wang YK; Li J; Li XY; Ji T; Bai SJ
J Cell Physiol; 2019 Aug; 234(8):12926-12933. PubMed ID: 30549040
[TBL] [Abstract][Full Text] [Related]
12. Circ-AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR-296-3p/E-cadherin signals.
Tang B; Li W; Ji TT; Li XY; Qu X; Feng L; Bai S
J Cell Mol Med; 2020 Aug; 24(15):8779-8788. PubMed ID: 32597022
[TBL] [Abstract][Full Text] [Related]
13. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells.
Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
Biochem Biophys Res Commun; 2017 Sep; 490(4):1407-1413. PubMed ID: 28698146
[TBL] [Abstract][Full Text] [Related]
15. Hsa_circRNA_102610 upregulation in Crohn's disease promotes transforming growth factor-β1-induced epithelial-mesenchymal transition
Yin J; Ye YL; Hu T; Xu LJ; Zhang LP; Ji RN; Li P; Chen Q; Zhu JY; Pang Z
World J Gastroenterol; 2020 Jun; 26(22):3034-3055. PubMed ID: 32587447
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy.
Yun J; Ren J; Liu Y; Dai L; Song L; Ma X; Luo S; Song Y
Bioengineered; 2022 Jan; 13(1):634-644. PubMed ID: 34898373
[TBL] [Abstract][Full Text] [Related]
17. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-494-3p Exacerbates Renal Epithelial Cell Dysfunction by Targeting SOCS6 under High Glucose Treatment.
Xue X; Liu M; Wang Y; Yang Y; Li Z; Shi R; Miao Y
Kidney Blood Press Res; 2022; 47(4):247-255. PubMed ID: 35038704
[TBL] [Abstract][Full Text] [Related]
19. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
[TBL] [Abstract][Full Text] [Related]
20. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]